Wellington Management Funds (Ireland) plc - Wellington Global Health Care Equity Fund CHF N AccU

Reference Data

ISIN IE00BD8GP507
Valor Number 39040681
Bloomberg Global ID WGHCNUC ID
Fund Name Wellington Management Funds (Ireland) plc - Wellington Global Health Care Equity Fund CHF N AccU
Fund Provider Wellington Management Company LLP Web: https://www.wellingtonfunds.com
Fund Provider Wellington Management Company LLP
Representative in Switzerland BNP Paribas, Paris, Zurich Branch
Zürich
Distributor(s) Wellington Global Administrator, Ltd.
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Ireland
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide.
Peculiarities

Fund Prices

Current Price * 10.39 CHF 20.12.2024
Previous Price * 10.46 CHF 19.12.2024
52 Week High * 12.02 CHF 16.07.2024
52 Week Low * 10.02 CHF 28.12.2023
NAV * 10.39 CHF 20.12.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 1,951,838,639
Unit/Share Assets *** 462,543
Trading Information SIX

Performance

YTD Performance +3.32% 29.12.2023
20.12.2024
1 month -2.87% 20.11.2024
20.12.2024
3 months -9.82% 20.09.2024
20.12.2024
6 months -7.39% 20.06.2024
20.12.2024
1 year +5.78% 20.12.2023
20.12.2024
2 years +0.60% 20.12.2022
20.12.2024
3 years -8.87% 20.12.2021
20.12.2024
5 years +3.88% 05.02.2020
20.12.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 8.93%
UnitedHealth Group Inc 7.35%
Novo Nordisk A/S 5.70%
Merck & Co Inc 4.33%
AstraZeneca PLC 4.26%
Boston Scientific Corp 2.96%
Danaher Corp 2.72%
argenx SE 2.59%
Intuitive Surgical Inc 2.56%
Novartis AG Registered Shares 2.55%
Last data update 31.10.2024

Cost / Risk

TER 1.33%
TER date 15.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 1.25%
Ongoing Charges *** 1.32%
SRRI ***
SRRI date *** 30.11.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)